During the past decade, Centrum Medyczne Medyk conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 21 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 19 clinical trials were completed. i.e. 76% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrum Medyczne Medyk" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Boehringer Ingelheim" with 5 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "Celgene" with 4 trials sponsored and "Pfizer" with 4 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Medyczne Medyk" #1 collaborator was "Eli Lilly and Company" with 5 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "ARMO BioSciences" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Dr. Falk Pharma GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Medyczne Medyk" are "Ulcerative Colitis" (9 trials), "Crohn Disease" (5 trials), "Crohn's Disease" (4 trials), "Colitis, Ulcerative" (3 trials) and "Multiple Sclerosis" (3 trials). Many other conditions were trialed in "Centrum Medyczne Medyk" in a lesser frequency.

Most popular intervention types in "Centrum Medyczne Medyk" are "Drug" (46 trials), "Biological" (8 trials), "Other" (6 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "Etrasimod" (4 trials), "Etrolizumab" (4 trials), "Guselkumab" (4 trials) and "Empagliflozin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Medyczne Medyk" are 50 trials for "All" genders.

Currently, there are NaN active trials in "Centrum Medyczne Medyk". undefined are not yet recruiting, 12 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Centrum Medyczne Medyk, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Medyczne Medyk, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".